New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.
His team provides comprehensive investment banking services to health, education and cultural institutions. Mr. Johnson has over 25 years of investment banking experience and has senior managed more ...
Dr David Johnson highlights some key studies. Medscape Gastroenterology, October 25, 2018 ACG 2018 Read clinically focused news coverage of key developments from ACG 2018. Medscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback